Ability of Serum IgE Concentration to Predict Exacerbation Risk and Benralizumab Efficacy for Patients With Severe Eosinophilic Asthma
Advances in Therapy - United States
doi 10.1007/s12325-019-01191-2
Full Text
Open PDFAbstract
Available in full text
Date
December 14, 2019
Authors
Publisher
Springer Science and Business Media LLC